Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Symbravo ingredients mechanism of action?Dabrafenib btd date 2023?Guselkumab loss of exclusitivy?When genetic tenofovir alafenamide be available in us?What are the most memorable drug brands in oral factor b inhibitors? in united states
See the DrugPatentWatch profile for cosentyx
Research suggests that Cosentyx, a biologic medicine used to treat plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis, may not have a significant impact on vaccine side effects at injection sites [1]. According to studies and the medication's prescribing information, Cosentyx does not have a direct effect on the body's ability to respond to vaccines or the safety of vaccines administered at injection sites. The medication primarily targets specific proteins (IL-17A and IL-17F) involved in inflammation and the body's immune response, without broadly affecting the immune system's function [[2]]. However, it is crucial to note that people taking immunosuppressive or immunomodulatory medications, like biologics, may have a slightly increased risk of vaccine side effects or reduced effectiveness of certain vaccinations [[3][4]]. This is due to their altered immune response, but this effect is not specific to Cosentyx [[5]]. Cosentyx's manufacturer, Novartis, recommends that patients taking the medication follow the standard vaccine schedule for their age group and health status, and consult their doctor or healthcare provider before receiving any vaccinations [[6]]. Sources: [1] https://www.drugpatentwatch.com/cosentyx/ [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441447/ [3] https://www.nejm.org/doi/10.1056/NEJMoa1709040? [4] https://www.ncbi.nlm.nih.gov/pubmed/29362244 [5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491136/ [6] https://www.uspir.com/uspi/cosentyx/hpi.html
Other Questions About Cosentyx :